Skip to content

A Clinical trial to evaluate the visual quality and comfort of wearing Wudu total aberration correction lenses

A Clinical trial to evaluate the visual quality and comfort of wearing Wudu total aberration correction lenses

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112395
Enrollment
Unknown
Registered
2025-11-13
Start date
2025-10-15
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive error

Interventions

Experimental Group:After wearing 0.05-day interval total aberration personalized correction lenses and going through a two-week elution period, 0.05-day interval single vision lenses were worn
Control group:Single-vision lenses with 0.05D intervals were worn. After a two-week elution period, total aberration personalized correction lenses with 0.05D intervals were worn

Sponsors

Tianjin Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Age =18 years old and =40 years old, gender is not limited; 2. Under binocular astigmatism, the equivalent spherical diopter of objective refraction is between = 0.00 D and = -10.00 D, the best corrected visual acuity in both eyes is =0.8; 3. Astigmatism = 4.00D 4. Voluntarily participate in this clinical trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those who have a history of ocular trauma or intraocular surgery; 2. Clinically significant slit lamp examination findings; 3. The result of the fundus examination is grade 2 or above; 4. Abnormal intraocular pressure (intraocular pressure 21mmHg or intraocular pressure difference between both eyes =5mmHg); 5. Patients with other ocular diseases, such as uveitis and various other inflammations, glaucoma, cataracts, retinal diseases, ocular tumors, ocular trauma, and overt strabismus; And any ocular lesions that affect visual function; 6. Patients with systemic diseases that cause weakened immunity, such as acute or chronic sinusitis, diabetes, Down syndrome, rheumatoid arthritis, mental patients, or other diseases that researchers consider unsuitable for wearing frame glasses, etc. 3. Those who have participated in drug clinical trials or used rigid contact lenses within 3 months; 8. Only one eye meets the inclusion criteria; 9. Those who fail to follow up regularly as required by the test; 10. Those who do not experience any improvement when wearing aberration try-on lenses; 11. The researchers determined that the candidates could not be selected

Design outcomes

Primary

MeasureTime frame
Strehl Ratio;

Secondary

MeasureTime frame
Subjective feeling score;high and low contrast visual acuity;

Countries

China

Contacts

Public ContactLi Lihua

Tianjin Eye Hospital

tysgzxlccs@163.com+86 22 2721 7663

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026